Osaic Holdings’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.04M Buy
20,939
+509
+2% +$51.4K ﹤0.01% 2064
2025
Q4
$1.63M Sell
20,430
-1,705
-8% -$112K ﹤0.01% 2266
2025
Q3
$1.01M Buy
22,135
+18,648
+535% +$730K ﹤0.01% 2782
2025
Q2
$128K Buy
3,487
+1,027
+42% +$39.5K ﹤0.01% 4296
2025
Q1
$87K Sell
2,460
-1,317
-35% -$53.5K ﹤0.01% 4273
2024
Q4
$165K Sell
3,777
-6,149
-62% -$310K ﹤0.01% 3771
2024
Q3
$450K Buy
9,926
+9,715
+4,604% +$423K ﹤0.01% 2975
2024
Q2
$8.19K Buy
+211
New +$7.89K ﹤0.01% 5905
2024
Q1
Sell
-1
Closed -$28 7375
2023
Q4
$28 Sell
1
-10
-91% -$240 ﹤0.01% 7192
2023
Q3
$303 Buy
+11
New +$326 ﹤0.01% 7079
2023
Q2
Sell
-164
Closed -$3.55K 7563
2023
Q1
$3.55K Buy
164
+77
+89% +$1.9K ﹤0.01% 6490
2022
Q4
$2K Buy
87
+69
+383% +$1.47K ﹤0.01% 6703
2022
Q3
$0 Hold
18
﹤0.01% 7475
2022
Q2
$0 Hold
18
﹤0.01% 7556
2022
Q1
$0 Buy
18
+9
+100% +$196 ﹤0.01% 7456
2021
Q4
$0 Buy
+9
New +$254 ﹤0.01% 7541
2020
Q4
Sell
-150
Closed -$5K 6542
2020
Q3
$5K Hold
150
﹤0.01% 5581
2020
Q2
$5K Buy
+150
New +$4.72K ﹤0.01% 5488

Other funds holding RVMD

Osaic Holdings's RVMD Position: Q1 2026 in Review

Osaic Holdings increased its Revolution Medicines (RVMD) stake by 2.5% in Q1 2026, buying an estimated $51.4K and bringing the position to 20,939 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

Osaic Holdings first reported a position in RVMD in Q2 2020 and has held it in 18 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Osaic Holdings held 20,939 shares of Revolution Medicines worth $2.04M as of Q1 2026.
  • Osaic Holdings bought 509 Revolution Medicines shares in Q1 2026, an estimated $51.4K.
  • Revolution Medicines made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2064 holding.
  • Osaic Holdings first reported a position in Revolution Medicines in Q2 2020 and has held it in 18 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.